Skip to main content

C-Reactive Protein Increases During Menstrual Cycle in Females With Sickle Cell Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on April 15, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, April 15, 2025 -- For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle, according to a study published online April 9 in Blood Vessels, Thrombosis & Hemostasis.

Jessica Wu, M.D., from Penn Medicine in Philadelphia, and colleagues examined the relationship between CRP and menstrual cycle in female individuals with SCD. Frozen plasma samples were analyzed from reproductive-age adults with SCD. The menstrual cycle phase was estimated at the time of collection by measuring estradiol, progesterone, and luteinizing hormone levels in female patient samples.

The researchers found that CRP levels did not differ significantly by SCD genotype (SS and SC), hydroxyurea use, or sex. In female individuals with SCD, significantly higher CRP levels were seen during the follicular versus the luteal phase (8.80 versus 0.82 mg/L).

"These results suggest a cyclic pattern of inflammation across the menstrual cycle in females with SCD that may contribute to perimenstrual vaso-occlusive episodes," the authors write. "These findings warrant prospective validation, exploration of the menstrual patterns of other markers associated with SCD pathophysiology, and correlation with clinical symptomatology."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted April 2025

Read this next

Diet Quality Plays Role in Age at Menarche

MONDAY, May 12, 2025 -- Eating a healthy diet as a child is linked to girls having their first menstrual period at an older age than those who consume a less healthy diet...

Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia

TUESDAY, April 29, 2025 -- For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital...

Open-Label Placebo Plus Treatment Rationale Effective for PMS

FRIDAY, March 28, 2025 -- Open-label placebo (OLP) provided with a treatment rationale is effective and safe for premenstrual syndrome (PMS), according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.